Dept. of the Army -- USAMRAA logo

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Dept. of the Army -- USAMRAA

Funding Amount

$10,080,000 total

Deadline

September 30, 2026

118 days left

Grant Type

federal

Overview

DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Distinctive Features: Potential impact and innovation are important features of the TIA. Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526ALSRPTIA
  • Total Funding: $10,080,000
  • Expected Awards: 12
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-research

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award. Now let's win it.

Start writing